126 related articles for article (PubMed ID: 38006528)
21. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
[TBL] [Abstract][Full Text] [Related]
22. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma.
Sasaki K; Uchikado Y; Omoto I; Arigami T; Osako Y; Noda M; Okumura H; Maemura K; Higashi R; Yoshiura T; Natsugoe S
Cancer Chemother Pharmacol; 2019 Mar; 83(3):581-587. PubMed ID: 30623230
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of positive lymph node regression grade to neoadjuvant chemoradiation for esophageal squamous cell carcinoma.
Yehan Z; Ying L; Peng G; Zongyao H; Chengmin Z; Hong Y; Sheng Q; Jie Z; Yi W; Xuefeng L; Wenwu H; Qifeng W; Yang L
J Surg Oncol; 2024 Mar; 129(4):708-717. PubMed ID: 38124398
[TBL] [Abstract][Full Text] [Related]
26. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
Sugiyama F; Kanda M; Kodera Y
Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma.
Li K; Leng X; Peng L
Ann Surg Oncol; 2024 Jun; 31(6):3850-3851. PubMed ID: 38466485
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Yamamoto M; Shinnno N; Hara H; Omori T; Motoori M; Ohue M; Yano M
Ann Surg Oncol; 2023 Jul; 30(7):4203-4204. PubMed ID: 37029864
[No Abstract] [Full Text] [Related]
29. ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma.
Okumura H; Noda M; Natsugoe S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):715-716. PubMed ID: 30288651
[No Abstract] [Full Text] [Related]
30. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy.
Ye G; Chen Z; Wang L; Hu Z; Bian Y; Yang X; Lu T; Zhan C; Lin Z; Wang Q
J Surg Oncol; 2020 Jun; 121(7):1074-1083. PubMed ID: 32141098
[TBL] [Abstract][Full Text] [Related]
31. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stageĀ II/III esophageal squamous cell carcinoma patients.
Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Pretreatment PET/CT Nodal Status on Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiation.
Chen JX; Lu TY; Fang HY; Lin YS; Lee JM
World J Surg; 2020 Jul; 44(7):2323-2331. PubMed ID: 32296872
[TBL] [Abstract][Full Text] [Related]
34. Supracarinal lymph node positivity in esophageal squamous cell carcinoma (ESCC) and factors predicting metastasis in supracarinal compartment nodes: Should a total mediastinal node dissection be the standard of care?
Jain AR; Sadhwani MA; Vyas RD; Pandya SJ; Sharma MR; Warikoo V; Puj KS; Salunke AA
Indian J Cancer; 2023; 60(2):185-190. PubMed ID: 37530239
[TBL] [Abstract][Full Text] [Related]
35. ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma-How to Do It?
Takeda FR; Tustumi F; Cecconello I
Ann Surg Oncol; 2020 Apr; 27(4):1248-1249. PubMed ID: 31673941
[No Abstract] [Full Text] [Related]
36. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
Zhang X; Eyck BM; Yang Y; Liu J; Chao YK; Hou MM; Hung TM; Pang Q; Yu ZT; Jiang H; Law S; Wong I; Lam KO; van der Wilk BJ; van der Gaast A; Spaander MCW; Valkema R; Lagarde SM; Wijnhoven BPL; van Lanschot JJB; Li Z
BMC Cancer; 2020 Mar; 20(1):194. PubMed ID: 32143580
[TBL] [Abstract][Full Text] [Related]
37. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
38. How Many Nodes Need to be Removed to Make Esophagectomy an Adequate Cancer Operation, and Does the Number Change When a Patient has Chemoradiotherapy Before Surgery?
Yeung JC; Bains MS; Barbetta A; Nobel T; DeMeester SR; Louie BE; Orringer MB; Martin LW; Reddy RM; Schlottmann F; Molena D
Ann Surg Oncol; 2020 Apr; 27(4):1227-1232. PubMed ID: 31605332
[TBL] [Abstract][Full Text] [Related]
39. ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
Wong LY; Berry MF
Ann Surg Oncol; 2023 Apr; 30(4):2224-2225. PubMed ID: 36607525
[No Abstract] [Full Text] [Related]
40. Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
Pao TH; Chen YY; Chang WL; Wu SY; Lai WW; Tseng YL; Chung TJ; Lin FC
PLoS One; 2024; 19(3):e0300173. PubMed ID: 38547184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]